BDBM50126021 CHEMBL23881::{4-[3-(4-Acetyl-3-hydroxy-2-propyl-phenoxy)-propylsulfanyl]-3-chloro-phenyl}-acetic acid

SMILES CCCc1c(O)c(ccc1OCCCSc1ccc(CC(O)=O)cc1Cl)C(C)=O

InChI Key InChIKey=ZOLCKIDHVSAZBR-UHFFFAOYSA-N

Data  7 IC50  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 10 hits for monomerid = 50126021   

TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50126021(CHEMBL23881 | {4-[3-(4-Acetyl-3-hydroxy-2-propyl-p...)
Affinity DataIC50:  580nMAssay Description:In vitro binding affinity for human PPAR gamma in SPAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor delta(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50126021(CHEMBL23881 | {4-[3-(4-Acetyl-3-hydroxy-2-propyl-p...)
Affinity DataEC50:  80nMAssay Description:Transcriptional activation by human PPAR deltaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor alpha(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50126021(CHEMBL23881 | {4-[3-(4-Acetyl-3-hydroxy-2-propyl-p...)
Affinity DataIC50:  7.40E+3nMAssay Description:In vitro binding affinity for human PPAR alpha in SPAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor alpha(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50126021(CHEMBL23881 | {4-[3-(4-Acetyl-3-hydroxy-2-propyl-p...)
Affinity DataEC50:  1.60E+3nMAssay Description:Transcriptional activation by human PPAR gammaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor alpha(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50126021(CHEMBL23881 | {4-[3-(4-Acetyl-3-hydroxy-2-propyl-p...)
Affinity DataIC50:  7.40E+3nMAssay Description:Agonist activity at PPARalphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50126021(CHEMBL23881 | {4-[3-(4-Acetyl-3-hydroxy-2-propyl-p...)
Affinity DataEC50:  230nMAssay Description:Transcriptional activation by human PPAR deltaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50126021(CHEMBL23881 | {4-[3-(4-Acetyl-3-hydroxy-2-propyl-p...)
Affinity DataIC50:  580nMAssay Description:Displacement of radio-labeled full agonist from PPARgamma receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor delta(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50126021(CHEMBL23881 | {4-[3-(4-Acetyl-3-hydroxy-2-propyl-p...)
Affinity DataIC50:  20nMAssay Description:Agonist activity at PPARdeltaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50126021(CHEMBL23881 | {4-[3-(4-Acetyl-3-hydroxy-2-propyl-p...)
Affinity DataIC50:  579nMAssay Description:Agonist activity at PPARgammaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeroxisome proliferator-activated receptor delta(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50126021(CHEMBL23881 | {4-[3-(4-Acetyl-3-hydroxy-2-propyl-p...)
Affinity DataIC50:  20nMAssay Description:In vitro binding affinity for human PPAR alpha in SPAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed